Poland· PL-100397810
Adablok
A solifenacin product containing solifenacini succinas, registered in Poland by Adamed Pharma S.A.. The same ATC class is registered in 18 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Solifenacin is registered in 18 of 19 countries.
Countries holding a registration under ATC G04BD08 (solifenacin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Solifenacin · ATC G04BD08
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of solifenacin costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.25 in France to $0.92 in Switzerland — a ×3.7 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Solifenacin · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.92
- ES Spain$0.77
- IT Italy$0.59
- FR France$0.25
The record
At a glance
URPL (Poland)- Active substance
- Solifenacini succinas
- Manufacturer
- Adamed Pharma S.A.
- Country
- Poland (PL)
- ATC code
- G04BD08
- ATC class
- Solifenacin
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
1 priced- gtin0590641400375830 szt.PLN 41.89
- gtin05900411002479
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
315 interactions on record for solifenacin.
Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Solifenacin · interactions on record
315 records
- 50 severe
- 210 moderate
- 3 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Potassium chlorideA12BA01severe
52 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Solifenacin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaARUSOLARDEZ Pharma, spol. s r.o., Kosoř
- SpainASOLFENA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGKrka D.D. Novo Mesto
- United Statessolifenacin succinateAjanta Pharma USA Inc.
- NetherlandsSolifenacine Aurobindo 10 mg, filmomhulde tablettenAurobindo Pharma B.V.
- FranceSOLIFENACINE ACCORD 10 mg, comprimé pelliculéACCORD HEALTHCARE FRANCE
- SwitzerlandSolifenacin NOBEL 10 mg, FilmtablettenNOBEL Pharma Schweiz AG
- FinlandSolifenacin AccordAccord Healthcare B.V.
- BelgiumPelvicare 10 mgCeres Pharma
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Solifenacin +pharma, Solifenacin 1a Pharma
- Belgium · Pelvicare, Solifenacin Ab
- Bulgaria · Truzor, Асолфена
- Cyprus · Saprax, Solifenacin Accord
- Czechia · Arusol, Asolfena
- Germany · Solifemin, Solifenacin 1 A Pharma
- Denmark · Solifenacin "sandoz", Solifenacin Krka
- Estonia · Asolfena, Solifenacin Nobel
- Spain · Dicrisol, Sincal
- Finland · Solifenacin Accord, Solifenacin Krka
- France · Solifenacine Accord, Solifenacine Arrow
- United Kingdom (Northern Ireland) · Seylacine Solifenacin Succinate, Solifenacin Jubilant Pharmaceuticals
- Greece · Cecure, Nacerfin
- Croatia · Asolfena, Beloflux
- Hungary · Asolfena, Belsanor
- Ireland · Solifenacin Clonmel, Solifenacin Succinate Accord Healthcare Ireland
- Iceland · Solifenacin Alvogen, Solifenacin Krka
- Italy · Incoves, Orodax
- Liechtenstein · Vesicare
- Lithuania · Asolfena, Gardurin
- Luxembourg · Pelvicare, Solifenacin Ratiopharm
- Latvia · Asolfena, Gardurin
- Malta · Solifenacin Pharmsol, Vesicare
- Netherlands · Solifenacinesuccinaat Accord, Solifenacinesuccinaat Aurobindo
- Norway · Solifenacin Accord, Solifenacin Krka
- Portugal · Blaxi, Solifenacina Alter
- Romania · Asolfena, Solifenacin Msn Laboratories
- Sweden · Solifenacin Accord, Solifenacin Glenmark
- Slovenia · Asolfena, Solifenacin Lek
- Slovakia · Aristissa, Arusol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/48e8088f-d70a-4cbd-944d-a5a22e87c7ba GET /v1/drugs/48e8088f-d70a-4cbd-944d-a5a22e87c7ba?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "10 mg",
"packaging": "05900411002479 ¦ Rp ¦ 129289\n30 tabl.\n05906414003758 ¦ Rp ¦ 129290\n30 tabl.",
"substance": "Solifenacini succinas 10 mg",
"common_name": "Solifenacini succinas",
"pl_product_id": "100397810",
"pozwolenie_nr": "24914",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about solifenacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.